EPP Life Sciences Pricing Forum 2024
Speakers
EPP Events bring unexceptional networking and conversations with
Thought Leaders, Pricing and Revenue Growth Management experts.
Our speaker faculty includes:
Ulrik Panton
Vice President Global Pricing
Novo Nordisk
Ulrik Panton
Ulrik is the Head of Global Pricing at Novo Nordisk. He has more than 10 years of pharmaceutical pricing, market access and commercial experience from industry and consulting. He has a Ph.D. and an M.Sc. degree in economics, both from the University of Copenhagen.
Patric Kirchner
Global Head of Pricing
Boehringer Ingelheim Animal Health
Patric Kirchner
Patric is a senior pricing expert. He combines extensive experience as a pricing and sales consultant, speaker, and trainer with real proven hands-on practical implementation knowledge. He worked many years for top consultancies (Simon-Kucher, PwC, Accenture) and is currently heading the global pricing team at Boehringer Ingelheim. He brings insights from many different industries and knows how to transfer cross-industry best practices and develop innovative solutions. He is working in pricing for more than 18 years and is a well-received advisor for start-ups as well as for large organizations.
Leandro Gandos Brito
Global Director Strategic Pricing
Sonova
Leandro Gandos Brito
Alan Crowther
General Manager Global Pricing Access Solution
Eversana
Alan Crowther
Alan has spent close to 20 years doing commercial work for the life sciences industry. His experience includes creating innovative solutions for global pricing and access, including work on price optimization, global data collection and analysis, and the use of advanced algorithms to support commercial decisions, including pricing.
Alan has shared his expertise and insight and has spoken extensively at a number of pharmaceutical conferences on drug and device pricing. He was previously the CEO of Alliance Life Sciences and prior to that held positions as vice president in life sciences at Adjoined/Capgemini and as managing officer in Andersen Consulting, where he led a number of large technology projects.
Alan is a graduate of Princeton University.
Sandro Cesaro
Head of Market Access & Innovative Value Strategies, Oncology Europe & Canada
AstraZeneca
Sandro Cesaro
Christian Raadamand Jensen
Senior Director Global Pricing
Lundbeck
Christian Raadamand Jensen
Christian has over a decade of experience in global pricing within the pharmaceutical industry. He currently leads the Global Pricing function at Lundbeck, a company dedicated to restoring brain health. Christian and his team develop and implement innovative pricing strategies that enhance access to treatments while ensuring sustainable profitability. He aspires to leverage his extensive experience from both operational and strategic roles, facilitating actionable and impactful implementation of pricing strategies.
Giovanni Tafuri
Director EU Market Access & Policy
Apellis Pharmaceuticals
Giovanni Tafuri
Raphael Prync
EMEA Pricing Strategy leader – Cardiovascular Surgery
Medtronic
Raphael Prync
Natalie Mochova
Strategic Partner Manager
Zentiva
Natalie Mochova
Natalie Mochova is a Global Strategic Pricing Manager at Zentiva, with over 10 years of experience in pricing across industries such as cybersecurity, industrial, banking and pharmaceuticals. Holding a PhD in Finance, Natalia specialises in developing innovative pricing strategies that drive business growth.
Tobias Happel
Senior Manager, Global Pricing & Competitive Portfolio Analytics
Philips
Tobias Happel
Vincent Blankert
Director Commercial Strategy, Pricing and Revenue Management
Zoetis
Vincent Blankert
As we strive for effective thought leadership, we aim to marry up global strategic initiatives with local day-to-day operations. I am grateful to have had the opportunity to enjoy years of experience in Pricing, sales and contract negotiations as well as trading and supply chain optimization. As I roll-out strategic initiatives, I continuously challenge myself to maintain a deep connection with the field and remind myself that success lies in the execution.
Marc Abels
Partner
Monitor Deloitte
Marc Abels
Marc has 20 years of experience in Go to market strategies and a deep expertise in pricing. He leads the Strategy & Analytics team (260 consultants) for Deloitte Belgium. He is one of the ‘pricing’ experts within Deloitte Europe and is a regular speaker on various pricing conferences (e.g. EPP- Pricing Platform).
Omar Ali
Head of Payers, Advisor on Value-Based Pricing
Verpora
Omar Ali
Qualified with a hospital pharmacy background, Omar has been working as the Formulary Advisor for Surrey & Sussex Healthcare NHS Trust for over 15 years, sitting on the regional Joint Drugs & Therapeutics Committee as well as the CCG/Commissioning Prescribing Clinical Network. Omar has been a visiting Lecturer at UCLH Pharmacy Programme and was both Lecturer & Examiner on the Independent Prescribing V300 Course at the University of Surrey and has over 30 publications to date. He has been appointed as Visiting Lecturer on Value Based Pricing & Innovative Contracting at the University of Portsmouth, is an Editorial Content Adviser to Guidelines, and has recently been invited to the position of Associate Editor to the Canadian Journal of Population Therapeutics & Clinical Pharmacology. Omar has served a position on the External Reference Group on Cost Impact Modelling for NICE for 6 years and was subsequently appointed Panel Member for the newly formed Adoption & Impact Program Reference for NICE. He advises foreign investors (US Embassy) on ‘Value Based Assessments (hosted by the UK Department of Trade & Industry) and recently delivered a Healthcare NHS Reform program to over 40 Healthcare Insurance Provider delegates visiting from the US. Last year he was invited to address the Italian Healthcare Senate [Senato della Repubblica] on Pharmaco-economic Evaluation & Sustainability Models of Healthcare and featured at the Westminster Health Forum Keynote Seminars [chaired by Lord Howe, All Party Parliamentary Group on Pharmacy] on the Future for Pharmacy Commissioning, Organisation & Delivery. At this current time he has embarked on a PhD with his doctorate thesis entitled “Value Based Pricing & Outcomes Based, Innovative Contracting of New Medicines”
Alejandra Garitonandia
LS Industry EMEA
Vistex
Alejandra Garitonandia
Alejandra Garitonandia is an Industry Principal for Life Sciences at Vistex EMEA. Her expertise and passion are in revenue management for pharma, medical device and animal health. A background in medical and business studies led to an international career spanning a variety of positions in business and IT. She is an international speaker and leads Life Sciences industry-driven initiatives focused on complex topics and trends.
Alejandra focuses on helping Life Sciences companies find their single source of truth where business processes meet IT systems to support efficient end-to-end revenue management.
Nico Mros
CXO & Founder
Lyfegen
Nico Mros
Nico Julian Mros is the Chief Customer Experience Officer and a co-founder of Lyfegen, a leading global provider of innovative drug access, pricing, and rebate management solutions. Since the company’s inception in 2018, Nico has been responsible for the implementation of over 2,500 value-based drug pricing contracts, across a diverse range of therapeutic areas including metabolic diseases, hematology, oncology, and central nervous system disorders. His work is driven by a commitment to improving healthcare delivery through practical, patient-centered approaches, with a particular focus on making high-cost therapies more accessible and affordable. Nico’s contributions have been instrumental in positioning Lyfegen as a key innovator with insurers, government bodies, payers, and pharmaceutical companies worldwide to establish and optimize the management of complex drug pricing agreements. Under his leadership, Lyfegen has rolled out cutting-edge platform products, including the world’s largest library of value-based contracts, a sophisticated drug contracting simulator, and an advanced agreement and rebate analytics platform.
Istvan Szabo
Msc HEOR, MBA Global Pricing & Market Access Consultant
Independent
Istvan Szabo
20+ years of Pharmaceutical & MedTech experience, enabled by an MBA, and Master’s in Health Economics - combined with Global & EMEA leadership roles at Novo Nordisk, Becton-Dickinson (BD), Baxter, BMS, and Eli Lilly, covering all regions.
25+ Global/EMEA product launches, following value-based pricing & access strategies. Experience with many therapeutic areas & product categories: general & specialty medicines, vaccines; medical devices, diagnostic products & services - including SaaS and platform-based solutions
Gianclaudio Floria
CEO
Pharmsight GmbH
Gianclaudio Floria
Gianclaudio Floria is the founder and CEO of Bright Light Consulting. He brings 20+ years in Pricing and Market Access across Hemato-Oncology, Immuno-Oncology, Nephrology, and Infectious Diseases. Six Sigma Green Belt certified, with 15+ years in team management. Former Global Pricing Head for Multiple Myeloma and Lymphoma Pricing at BMS. Held leadership roles at Alexion, Fresenius Kabi Biosimilars, Amgen, and Gilead Sciences. Author, speaker, and Microsoft MVP for Excel. MBA from Mib School of Management, degree in Political Economy Science from University of Trieste. Expert in Financial and BI IT tools, with a passion for AI.
Chirag Maheshwari
CTO
Pharmsight GmbH
Chirag Maheshwari
Chirag is the Co-Founder & Director of Analytics at Pharmsight Research and Analytics, leading a team of 20 members. With 13 years of experience in Forecasting, Analytics, Pricing Management, Strategic Insights, and Real-World evidence generation, Chirag has collaborated with 10 of the top 20 pharmaceutical companies. He has established Centers of Excellence around Pricing Management, IRP, Performance Analytics, Commercial and Patient Analytics, Tender Management, and HEOR. Additionally, he has developed AI-enabled solutions for Pharma Analytics. Chirag holds an M.Sc in Physics and a Bachelor of Pharmacy from BITS Pilani.